Evidence map›Paper›PMID 29534692›Full record

ArticleBMC pediatrics2018

Diagnosis and therapeutic monitoring of inborn errors of metabolism in 100,077 newborns from Jining city in China.

Chi-Ju Yang, Na Wei, Ming Li, Kun Xie, Jian-Qiu Li, Cheng-Gang Huang, Yong-Sheng Xiao, Wen-Hua Liu, Xi-Gui Chen

Open access · goldAbstract read
In one paragraph

Article in BMC pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chi-Ju YangCenter of Neonatal Disease Screening, Maternal and Child Health Care Hospital, Number 12, Gongxiao Road, Jining, Shandong Province, People's Republic of China.
Na WeiClinical Laboratory of Linyi People's Hospital, Linyi, Shandong Province, People's Republic of China.
Ming LiCenter of Neonatal Disease Screening, Maternal and Child Health Care Hospital, Number 12, Gongxiao Road, Jining, Shandong Province, People's Republic of China.
Kun XieZhejiang Biosan Biochemical Technologies Co., Ltd., Hangzhou, Zhejiang Province, People's Republic of China.
Jian-Qiu LiZhejiang Biosan Biochemical Technologies Co., Ltd., Hangzhou, Zhejiang Province, People's Republic of China.
Cheng-Gang HuangZhejiang Biosan Biochemical Technologies Co., Ltd., Hangzhou, Zhejiang Province, People's Republic of China.
Yong-Sheng XiaoZhejiang Biosan Biochemical Technologies Co., Ltd., Hangzhou, Zhejiang Province, People's Republic of China.
Wen-Hua LiuZhejiang Biosan Biochemical Technologies Co., Ltd., Hangzhou, Zhejiang Province, People's Republic of China.
Xi-Gui ChenCenter of Neonatal Disease Screening, Maternal and Child Health Care Hospital, Number 12, Gongxiao Road, Jining, Shandong Province, People's Republic of China. chenxigui1122@163.com.
Shandong Maternal and Child Health Hospital · CNLinyi People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMandatory newborn screening for metabolic disorders has not been implemented in most parts of China. Newborn mortality and morbidity could be markedly reduced by early diagnosis and treatment of inborn errors of metabolism (IEM). Methods of screening for IEM by tandem mass spectrometry (MS/MS) have been developed, and their advantages include rapid testing, high sensitivity, high specificity, high throughput, and low sample volume (a single dried blood spot).

methodsDried blood spots of 100,077 newborns obtained from Jining city in 2014-2015 were screened by MS/MS. The screening results were further confirmed by clinical symptoms and biochemical analysis in combination with the detection of neonatal deficiency in organic acid, amino acid, or fatty acid metabolism and DNA analysis.

resultsThe percentages of males and females among the 100,077 infants were 54.1% and 45.9%, respectively. Cut-off values were established by utilizing the percentile method. The screening results showed that 98,764 newborns were healthy, and 56 out of the 1313 newborns with suspected IEM were ultimately diagnosed with IEM. Among these 56 newborns, 19 (1:5267) had amino acid metabolism disorders, 26 (1:3849) had organic acid metabolism disorders, and 11 (1:9098) had fatty acid oxidation disorders. In addition, 54 patients with IEM were found to carry mutations, and the other 2 patients had argininemia.

conclusionsFifty-six cases of metabolic disorders in Jining were confirmed via newborn screening (NBS) by MS/MS. Early diagnosis and treatment are crucial for the survival and well-being of affected children. A nationwide NBS program using MS/MS is recommended, especially in poor areas of China.

Indexed as

ChinaDried Blood Spot TestingEarly DiagnosisFemaleHumansIncidenceInfant, NewbornMaleMetabolism, Inborn ErrorsNeonatal ScreeningSensitivity and SpecificityTandem Mass SpectrometryAminoacidemiaFatty acid oxidation disordersInborn errors of metabolism (IEM)Organic acidemiaTandem mass spectrometry

Identifiers

PMID29534692
PMCPMC5850921
OpenAlexW2799913847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.